Cargando…

Metabolic Pathways Enhancement Confers Poor Prognosis in p53 Exon Mutant Hepatocellular Carcinoma

RNA-Sequencing (RNA-Seq), the most commonly used sequencing application tool, is not only a method for measuring gene expression but also an excellent media to detect important structural variants such as single nucleotide variants (SNVs), insertion/deletion (Indels), or fusion transcripts. The Canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Po-Ming, Li, Jian-Rong, Liu, Chun-Chi, Tang, Feng-Yao, Chiang, En-Pei Isabel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947881/ https://www.ncbi.nlm.nih.gov/pubmed/31933519 http://dx.doi.org/10.1177/1176935119899913

Ejemplares similares

Downregulation of Methionine Cycle Genes MAT1A and GNMT Enriches Protein-Associated Translation Process and Worsens Hepatocellular Carcinoma Prognosis
por: Chen, Po-Ming, et al.
Publicado: (2022)

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Overexpression of RBBP6, Alone or Combined with Mutant TP53, Is Predictive of Poor Prognosis in Colon Cancer
por: Chen, Jian, et al.
Publicado: (2013)

CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients
por: Yao, Yang, et al.
Publicado: (2019)

p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis
por: Matin, Rubeta N., et al.
Publicado: (2013)

S127: DELTATP73 IMPOSES TP53 MUTANT-LIKE PHENOTYPES INCLUDING DRUG RESISTANCE AND POOR PROGNOSIS ON TP53-WILD TYPE ACUTE MYELOID LEUKEMIA.
por: Pereira-Martins, Diego A, et al.
Publicado: (2023)

Exon 11 homozygous mutations and intron 10/exon 11 junction deletions in the KIT gene are associated with poor prognosis of patients with gastrointestinal stromal tumors
por: Shen, Yan‐Ying, et al.
Publicado: (2020)

Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2
por: Tung, Min-Che, et al.
Publicado: (2015)

Mutant p53 and Twist1 Co-Expression Predicts Poor Prognosis and Is an Independent Prognostic Factor in Breast Cancer
por: Zhang, Yong-Qu, et al.
Publicado: (2021)

DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
por: Lai, Ssu-Chuan, et al.
Publicado: (2019)

Expression of MTDH and IL-10 Is an Independent Predictor of Worse Prognosis in ER-Negative or PR-Negative Breast Cancer Patients
por: Chu, Pei-Yi, et al.
Publicado: (2020)

Docosahexaenoic acid inhibits the proliferation of Kras/TP53 double mutant pancreatic ductal adenocarcinoma cells through modulation of glutathione level and suppression of nucleotide synthesis
por: Hung, Wei-Chia, et al.
Publicado: (2020)

Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis
por: Yeh, Hsi-Wen, et al.
Publicado: (2017)

Translocation of Methionine Adenosyl Transferase MAT2A and Its Prognostic Relevance for Liver Hepatocellular Carcinoma
por: Chu, Pei-Yi, et al.
Publicado: (2023)

Downregulation of tumor protein 53-inducible nuclear protein 1 expression in hepatocellular carcinoma correlates with poor prognosis
por: Deng, Yan, et al.
Publicado: (2017)

Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
por: Lai, Ssu-Chuan, et al.
Publicado: (2020)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcome
por: Zhang, Yao, et al.
Publicado: (2016)

Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
por: ZHANG, ZHEN-HAI, et al.
Publicado: (2014)

The Vessels That Encapsulate Tumor Clusters (VETC) Pattern Is a Poor Prognosis Factor in Patients with Hepatocellular Carcinoma: An Analysis of Microvessel Density
por: Huang, Chun-Wei, et al.
Publicado: (2022)

PIK3CA exon 20 mutations are associated with poor prognosis in breast cancer patients
por: Mangone, Flavia R., et al.
Publicado: (2012)

Relationship between codon 249 mutation in exon 7 of p53 gene and diagnosis of hepatocellular carcinoma
por: El-Din, Hesham Gamal, et al.
Publicado: (2010)

Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Cytoplasmic p53 aggregates accumulated in p53-mutated cancer correlate with poor prognosis
por: Iwahashi, Naoyuki, et al.
Publicado: (2022)

Increased level of nucleolin confers to aggressive tumor progression and poor prognosis in patients with hepatocellular carcinoma after hepatectomy
por: Guo, XiaoDong, et al.
Publicado: (2014)

Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma()()
por: Fu, Jia, et al.
Publicado: (2015)

Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma
por: Lee, Hye-Jin, et al.
Publicado: (2015)

Concurrent TP53 mutations predict a poor prognosis of EGFR-mutant NSCLCs treated with TKIs: An updated systematic review and meta-analysis
por: Lan, Bo, et al.
Publicado: (2022)

Adult abuse and poor prognosis in Taiwan, 2000–2015: a cohort study
por: Yu, Pi-Ching, et al.
Publicado: (2022)

Decreased expression of protocadherin 20 is associated with poor prognosis in hepatocellular carcinoma
por: Wu, Yanqin, et al.
Publicado: (2016)

FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma
por: Wang, Yan, et al.
Publicado: (2020)

High expression of GNA13 is associated with poor prognosis in hepatocellular carcinoma
por: Xu, Yi, et al.
Publicado: (2016)

Personalized quantitative models of NAD metabolism in hepatocellular carcinoma identify a subgroup with poor prognosis
por: Chedere, Adithya, et al.
Publicado: (2022)

Antibodies against p53 are associated with poor prognosis of colorectal cancer.
por: Houbiers, J. G., et al.
Publicado: (1995)

p53 protein expression in nephroblastomas: a predictor of poor prognosis.
por: Govender, D., et al.
Publicado: (1998)

p53 mutation, deprivation and poor prognosis in primary breast cancer
por: Baker, L, et al.
Publicado: (2010)

Nuclear p53 Immunoreaction Associated with Poor Prognosis of Breast Cancer
por: Iwaya, Keiichi, et al.
Publicado: (1991)

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
por: Margetts, Jane, et al.
Publicado: (2018)

Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients
por: Ruan, Jian, et al.
Publicado: (2016)

NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity
por: Li, Qijiong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0eqvp5f56dkk3atfvl2vacv77u